ABL: A Protein Involved in Cell Growth, Apoptosis and Signaling Pathways

Target Name: Tyrosine-Protein Kinase ABL

NCBI ID: P10308

Tyrosine-Protein Kinase ABL

Other Name(s): Abelson tyrosine-protein kinase | Protein Kinase ABL

ABL: A Protein Involved in Cell Growth, Apoptosis and Signaling Pathways

Tyrosine-Protein Kinase ABL (nonspecific subtype), also known as Abelson tyrosine-protein kinase, is a protein that is expressed in various tissues and cell types throughout the body. It plays a crucial role in the regulation of cell growth, apoptosis, and signaling pathways. The nonspecific subtype of ABL is a specific subtype of ABL that is expressed in various tissues, including the brain, heart, liver, and muscle.

ABL is a protein that is composed of 111 amino acid residues and has a molecular weight of 13.9 kDa. It has four known isoforms, ABL1, ABL2, ABL3, and ABL4, which differ in their catalytic site. ABL1 is the most abundant isoform and is expressed in various tissues, including the brain, heart, liver, and muscle. ABL2 and ABL3 are also expressed in these tissues, but to a lesser extent than ABL1. ABL4 is the least abundant isoform and is only expressed in the heart.

The ABL signaling pathway is involved in the regulation of cell growth, apoptosis, and signaling pathways. It is a negative regulator of the PI3K/Akt signaling pathway and has been shown to play a role in the regulation of cell proliferation, differentiation, and survival . ABL has also been shown to play a role in the regulation of cell apoptosis, by promoting the production of pro-apoptotic factors and inhibiting the production of anti-apoptotic factors.

ABL has also been shown to be involved in the regulation of protein kinase (PK) signaling pathways. PK is a complex that regulates the activity of various enzymes and is involved in the regulation of cellular processes such as cell growth, apoptosis, and signaling pathways . ABL has been shown to play a role in the regulation of PK signaling pathways by phosphorylation and dephosphorylation of several key enzymes involved in this pathway, including PAK1, PKC3, and PKD2.

Due to its involvement in the regulation of cell growth, apoptosis, and signaling pathways, ABL has been identified as a potential drug target. Several studies have shown that inhibition of ABL activity can lead to the inhibition of various cellular processes, including cell growth, apoptosis, and signaling pathways. Additionally, ABL has been shown to be involved in the regulation of PK signaling pathways, which are often targeted by drugs used to treat various diseases, such as cancer, neurodegenerative diseases, and autoimmune diseases.

In conclusion, ABL is a protein that is involved in the regulation of cell growth, apoptosis, and signaling pathways. Its role in these processes makes it a potential drug target. The nonspecific subtype of ABL is the most abundant and is expressed in various tissues , including the brain, heart, liver, and muscle. Further research is needed to fully understand the role of ABL in the regulation of these processes and to identify potential drug targets.

Protein Name: Tyrosine-Protein Kinase ABL (nonspecified Subtype)

The "Tyrosine-Protein Kinase ABL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Tyrosine-Protein Kinase ABL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets